ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Bloomsbury Genetic Therapies Limited

Bloomsbury Genetic Therapies Limited is an active company incorporated on 31 August 2021 with the registered office located in Cambridge, Cambridgeshire. Bloomsbury Genetic Therapies Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13593877
Private limited company
Age
4 years
Incorporated 31 August 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 30 August 2025 (4 months ago)
Next confirmation dated 30 August 2026
Due by 13 September 2026 (8 months remaining)
Last change occurred 2 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
Building 1000 Cambridge Research Park
Beach Drive
Waterbeach
Cambridgeshire
CB25 9PD
England
Address changed on 8 Jan 2024 (2 years ago)
Previous address was 30 Broad Street Great Cambourne Cambridge CB23 6HJ England
Telephone
Unreported
Email
Unreported
People
Officers
1
Shareholders
12
Controllers (PSC)
2
Director • American • Lives in England • Born in Sep 1983
UTF General Partner 2 LLP
PSC
UCL Business Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
UCLTF Corporate Directors Ltd
Leigh Pauline Brody is a mutual person.
Active
Formicor Pharmaceuticals Ltd
Leigh Pauline Brody is a mutual person.
Active
Brands
Bloomsbury Genetic Therapies
Bloomsbury Genetic Therapies is a clinical-stage biotechnology company focused on developing gene therapy treatments for patients with rare neurological and metabolic diseases.
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£600.37K
Decreased by £1.83M (-75%)
Turnover
Unreported
Same as previous period
Employees
4
Decreased by 2 (-33%)
Total Assets
£754.57K
Decreased by £2.19M (-74%)
Total Liabilities
-£220.52K
Decreased by £1.42M (-87%)
Net Assets
£534.06K
Decreased by £761.48K (-59%)
Debt Ratio (%)
29%
Decreased by 26.72% (-48%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 13 Nov 2025
Confirmation Submitted
2 Months Ago on 6 Nov 2025
Adrien Felix Lemoine Resigned
8 Months Ago on 30 Apr 2025
Frank Armstrong Resigned
9 Months Ago on 7 Apr 2025
Andrea Hebe Spezzi Resigned
9 Months Ago on 20 Mar 2025
Sara Inmaculada Garcia Gomez Resigned
9 Months Ago on 19 Mar 2025
Michael Craig Diem Resigned
9 Months Ago on 18 Mar 2025
John Edward Ilett Resigned
10 Months Ago on 5 Mar 2025
Confirmation Submitted
1 Year 3 Months Ago on 24 Sep 2024
Full Accounts Submitted
1 Year 6 Months Ago on 16 Jun 2024
Get Credit Report
Discover Bloomsbury Genetic Therapies Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 13 Nov 2025
Confirmation statement made on 30 August 2025 with updates
Submitted on 6 Nov 2025
Termination of appointment of John Edward Ilett as a secretary on 5 March 2025
Submitted on 6 Nov 2025
Resolutions
Submitted on 8 Jul 2025
Memorandum and Articles of Association
Submitted on 8 Jul 2025
Termination of appointment of Adrien Felix Lemoine as a director on 30 April 2025
Submitted on 30 Apr 2025
Termination of appointment of Frank Armstrong as a director on 7 April 2025
Submitted on 7 Apr 2025
Termination of appointment of Michael Craig Diem as a director on 18 March 2025
Submitted on 26 Mar 2025
Termination of appointment of Sara Inmaculada Garcia Gomez as a director on 19 March 2025
Submitted on 26 Mar 2025
Termination of appointment of Andrea Hebe Spezzi as a director on 20 March 2025
Submitted on 20 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year